Cargando…

Paraneoplastic pemphigus and myasthenia gravis, associated with inflammatory pseudotumor‐like follicular dendritic cell sarcoma: response to rituximab

Paraneoplastic pemphigus (PNP) is an autoimmune blistering disease associated with neoplasms. The disease is most commonly of lymphoproliferative origin and presents high mortality. We describe a patient with PNP and myasthenia gravis associated with inflammatory pseudotumor‐like follicular dendriti...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lifang, Deng, Hui, Mao, Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974432/
https://www.ncbi.nlm.nih.gov/pubmed/27525088
http://dx.doi.org/10.1002/ccr3.625
_version_ 1782446541967982592
author Wang, Lifang
Deng, Hui
Mao, Mei
author_facet Wang, Lifang
Deng, Hui
Mao, Mei
author_sort Wang, Lifang
collection PubMed
description Paraneoplastic pemphigus (PNP) is an autoimmune blistering disease associated with neoplasms. The disease is most commonly of lymphoproliferative origin and presents high mortality. We describe a patient with PNP and myasthenia gravis associated with inflammatory pseudotumor‐like follicular dendritic cell sarcoma, as well as the response to rituximab.
format Online
Article
Text
id pubmed-4974432
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-49744322016-08-12 Paraneoplastic pemphigus and myasthenia gravis, associated with inflammatory pseudotumor‐like follicular dendritic cell sarcoma: response to rituximab Wang, Lifang Deng, Hui Mao, Mei Clin Case Rep Case Reports Paraneoplastic pemphigus (PNP) is an autoimmune blistering disease associated with neoplasms. The disease is most commonly of lymphoproliferative origin and presents high mortality. We describe a patient with PNP and myasthenia gravis associated with inflammatory pseudotumor‐like follicular dendritic cell sarcoma, as well as the response to rituximab. John Wiley and Sons Inc. 2016-07-15 /pmc/articles/PMC4974432/ /pubmed/27525088 http://dx.doi.org/10.1002/ccr3.625 Text en © 2016 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Case Reports
Wang, Lifang
Deng, Hui
Mao, Mei
Paraneoplastic pemphigus and myasthenia gravis, associated with inflammatory pseudotumor‐like follicular dendritic cell sarcoma: response to rituximab
title Paraneoplastic pemphigus and myasthenia gravis, associated with inflammatory pseudotumor‐like follicular dendritic cell sarcoma: response to rituximab
title_full Paraneoplastic pemphigus and myasthenia gravis, associated with inflammatory pseudotumor‐like follicular dendritic cell sarcoma: response to rituximab
title_fullStr Paraneoplastic pemphigus and myasthenia gravis, associated with inflammatory pseudotumor‐like follicular dendritic cell sarcoma: response to rituximab
title_full_unstemmed Paraneoplastic pemphigus and myasthenia gravis, associated with inflammatory pseudotumor‐like follicular dendritic cell sarcoma: response to rituximab
title_short Paraneoplastic pemphigus and myasthenia gravis, associated with inflammatory pseudotumor‐like follicular dendritic cell sarcoma: response to rituximab
title_sort paraneoplastic pemphigus and myasthenia gravis, associated with inflammatory pseudotumor‐like follicular dendritic cell sarcoma: response to rituximab
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974432/
https://www.ncbi.nlm.nih.gov/pubmed/27525088
http://dx.doi.org/10.1002/ccr3.625
work_keys_str_mv AT wanglifang paraneoplasticpemphigusandmyastheniagravisassociatedwithinflammatorypseudotumorlikefolliculardendriticcellsarcomaresponsetorituximab
AT denghui paraneoplasticpemphigusandmyastheniagravisassociatedwithinflammatorypseudotumorlikefolliculardendriticcellsarcomaresponsetorituximab
AT maomei paraneoplasticpemphigusandmyastheniagravisassociatedwithinflammatorypseudotumorlikefolliculardendriticcellsarcomaresponsetorituximab